Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
The barrier formed by endothelial cells (ECs) plays an important role in tissue homeostasis by restricting passage of circulating molecules and inflammatory cells. Disruption of the endothelial barrier in pathologic conditions often leads to uncontrolled inflammation and tissue damage. An important component of this barrier is adherens junctions, which restrict paracellular permeability. The transmembrane protein vascular endothelial (VE)-cadherin and its cytoplasmic binding partner β-catenin are major components of functional adherens junctions. We show that mesenchymal stem cells (MSCs) significantly reduce endothelial permeability in cocultured human umbilical vascular endothelial cells (HUVECs) and following exposure to vascular endothelial growth factor, a potent barrier permeability-enhancing agent. When grown in cocultures with HUVECs, MSCs increased VE-cadherin levels and enhanced recruitment of both VE-cadherin and β-catenin to the plasma membrane. Enhanced membrane localization of β-catenin was associated with a decrease in β-catenin-driven gene transcription. Disruption of the VE-cadherin/β-catenin interaction by overexpressing a truncated VE-cadherin lacking the β-catenin interacting domain blocked the permeability-stabilizing effect of MSCs. Interestingly, a conditioned medium from HUVEC-MSC cocultures, but not from HUVEC or MSC cells cultured alone, significantly reduced endothelial permeability. In addition, intravenous administration of MSCs to brain-injured rodents reduced injury-induced enhanced blood-brain barrier permeability. Similar to the effect on in vitro cultures, this stabilizing effect on blood-brain barrier function was associated with increased expression of VE-cadherin. Taken together, these results identify a putative mechanism by which MSCs can modulate vascular EC permeability. Further, our results suggest that the mediator(s) of these vascular protective effects is a secreted factor(s) released as a result of direct MSC-EC interaction.
Pati
Shibani
S
Department of Surgery, University of Texas Health Sciences Center, Houston, TX, USA. shibani.pati@uth.tmc.edu
Khakoo
Aarif Y
AY
Zhao
Jing
J
Jimenez
Fernando
F
Gerber
Michael H
MH
Harting
Matthew
M
Redell
John B
JB
Grill
Raymond
R
Matsuo
Yoichi
Y
Guha
Sushovan
S
Cox
Charles S
CS
Reitz
Marvin S
MS
Holcomb
John B
JB
Dash
Pramod K
PK
D000818:Animals; D015703:Antigens, CD / Q000378:metabolism*; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000473:pathology; D001930:Brain Injuries / Q000473:pathology / Q000628:therapy; D015820:Cadherins / Q000378:metabolism*; D002199:Capillary Permeability / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D018920:Coculture Techniques; D017077:Culture Media, Conditioned / Q000494:pharmacology; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D011485:Protein Binding / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects; D014158:Transcription, Genetic / Q000187:drug effects; D014471:Umbilical Veins / Q000166:cytology; D051176:beta Catenin / Q000378:metabolism*; D000099152:Cadherin 5
D015703:Antigens, CD; D015820:Cadherins; D017077:Culture Media, Conditioned; D051176:beta Catenin; D000099152:Cadherin 5
J Cell Biol. 1992 Sep;118(6):1511-22
1522121
Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2286-97
10521356
Methods Mol Biol. 2008;449:27-44
18370081
Lancet. 2004 May 1;363(9419):1439-41
15121408
Nature. 2007 Oct 4;449(7162):557-63
17914389
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11474-9
16061805
Nat Med. 2009 Jan;15(1):42-9
19098906
J Cell Mol Med. 2009 Jul;13(7):1348-57
18544044
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3243-8
17360632
J Biol Chem. 2005 Sep 9;280(36):31906-12
16027153
Thromb Res. 2007;120 Suppl 2:S1-6
18023702
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9815-20
10449777
Biochim Biophys Acta. 1999 Oct 29;1424(2-3):M23-37
10528152
J Cell Sci. 2008 Jul 1;121(Pt 13):2115-22
18565824
Physiol Rev. 2004 Jul;84(3):869-901
15269339
J Exp Med. 2006 May 15;203(5):1235-47
16636132
Chem Biol. 2000 Oct;7(10):793-803
11033082
J Cereb Blood Flow Metab. 2007 Oct;27(10):1684-91
17356562
J Biol Chem. 2003 May 23;278(21):19199-208
12626512
J Virol. 2001 Sep;75(18):8660-73
11507211
Science. 1997 Mar 21;275(5307):1787-90
9065402
Mol Biol Cell. 1998 Jun;9(6):1589-601
9614196
J Cell Biochem. 2009 Jul 1;107(4):706-13
19415686
J Cell Biol. 1998 Mar 23;140(6):1475-84
9508779
Int Arch Allergy Immunol. 1999 Nov;120(3):237-44
10592470
Nat Cell Biol. 2008 Aug;10(8):923-34
18604199
PLoS One. 2008 Apr 02;3(4):e1886
18382669
Nature. 1999 Apr 1;398(6726):422-6
10201372
J Neurosci Res. 2005 Nov 15;82(4):499-506
16211562
J Cell Sci. 1998 Jul;111 ( Pt 13):1853-65
9625748
J Immunol. 2007 Aug 1;179(3):1855-63
17641052
Cell Stem Cell. 2009 Jul 2;5(1):54-63
19570514
Int J Mol Med. 2008 Sep;22(3):325-32
18698491
FASEB J. 2006 Apr;20(6):661-9
16581974
Am J Physiol Cell Physiol. 2008 Apr;294(4):C977-84
18287330
Cell. 1999 Jul 23;98(2):147-57
10428027
Science. 2004 Mar 5;303(5663):1483-7
15001769
EMBO J. 2002 Sep 16;21(18):4885-95
12234928
Blood. 2005 Apr 1;105(7):2771-6
15604224
J Neurosci. 2007 Sep 19;27(38):10240-8
17881530
Nat Rev Immunol. 2008 Sep;8(9):726-36
19172693
J Cell Sci. 1999 Jun;112 ( Pt 12):1915-23
10341210
Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2285-95
18344375
Stem Cells Dev. 2009 Jun;18(5):683-92
19099374